iSpecimen Inc.
ISPC
$1.32
$0.010.76%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -43.77% | -13.05% | -6.42% | 0.74% | 3.82% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -43.77% | -13.05% | -6.42% | 0.74% | 3.82% |
Cost of Revenue | -24.11% | 6.14% | 10.01% | 12.56% | 14.21% |
Gross Profit | -63.36% | -32.56% | -21.92% | -9.56% | -4.82% |
SG&A Expenses | -13.99% | -10.15% | 3.74% | -11.22% | -13.93% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -18.50% | -7.04% | 4.37% | -2.92% | -3.32% |
Operating Income | -7.40% | 2.25% | -13.96% | 6.53% | 9.69% |
Income Before Tax | 0.03% | 2.73% | -12.60% | 6.50% | 8.73% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 0.03% | 2.73% | -12.60% | 6.50% | 8.73% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 0.03% | 2.73% | -12.60% | 6.50% | 8.73% |
EBIT | -7.40% | 2.25% | -13.96% | 6.53% | 9.69% |
EBITDA | -7.16% | 2.86% | -13.35% | 7.95% | 10.92% |
EPS Basic | 60.13% | 53.43% | 28.67% | 16.31% | 13.81% |
Normalized Basic EPS | 60.13% | 53.43% | 28.68% | 16.31% | 13.81% |
EPS Diluted | 60.13% | 53.43% | 28.67% | 16.42% | 13.91% |
Normalized Diluted EPS | 60.13% | 53.43% | 28.68% | 16.31% | 13.81% |
Average Basic Shares Outstanding | 243.83% | 159.36% | 57.21% | 20.28% | 7.85% |
Average Diluted Shares Outstanding | 243.83% | 159.36% | 57.21% | 20.28% | 7.85% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |